Agenda
Instructions to Access Sessions and earn CE Credits
- Expand each session and select "Access Session" to access the individual session.
- Within the session, you can download the slides in the Handouts section, and read about the speaker, description, and learning objectives.
- Access the session video in the Session Content tab.
- After each session, complete the CE evaluation, also located in the Session Content tab. You must complete an evaluation for each session you attend to earn CE credits for that session.
Day 1, September 25, 2024
Wed, Sep 25 at 7:00 am PDT
Day 1: Opening Remarks & The 2024 Erin Kay Flatley Spirit Award Winners
Overview
Description:
Date/Time: September 25, 2024 | 10:00 - 10:15 am ET
During these opening remarks, Sepsis Alliance will introduce this year’s 2024 Erin Kay Flatley Spirit Award Winner. Attendees will hear from the two awardees, as they share their sepsis stories and advocacy work they both do to help prevent, educate, and drive awareness of the deadly impact of sepsis.
The Erin Kay Flatley Spirit Award recognizes outstanding dedication, sacrifice, and contribution to improving sepsis awareness and reducing the suffering caused by sepsis. Dr. Carl Flatley, the founder of Sepsis Alliance and Erin’s dad, will once more introduce this year’s awardees and present them with the award.
Target Audience:
Nurses, advanced practice providers, physicians, emergency responders, pharmacists, medical technologists, respiratory therapists, physical/occupational therapists, infection prevention specialists, data/quality specialists, and more.
Speaker(s)
Carl Flatley, DDS, MSD, Founder
Jackie Duda, Health and Travel Journalist , Sepsis and Disability Advocate
Julia Fraser, Sepsis Survivor, Mrs. Texas
Wed, Sep 25 at 7:20 am PDT
Day 1 Keynote: Advocacy and Awareness: Our Family's Journey with Sepsis and the Power of ‘Using Your Voice’
Overview
Description:
Date/Time: September 25, 2024 | 10:20 - 10:30 am ET
During this impactful keynote session, Jake Tapper and his daughter Alice Tapper will share their family’s personal and deeply moving story of how a preventable missed diagnosis of appendicitis led to Alice developing sepsis. They will discuss their family's mission to raise awareness about sepsis, emphasize the importance of listening to patients and their families, and highlight Alice's advocacy work, including her new book, "Use Your Voice." Attendees will gain insights into the critical role healthcare professionals play in preventing sepsis and the power of patient and family advocacy.
Learning Objectives:
At the end of this session, the learner should be able to:
- Describe the potential consequences of delayed or missed diagnoses and their impact on patient outcomes;
- Recognize the importance of patient and family advocacy in healthcare and how to incorporate their perspectives into clinical decision-making.
Target Audience:
Nurses, advanced practice providers, physicians, emergency responders, pharmacists, medical technologists, respiratory therapists, physical/occupational therapists, infection prevention specialists, data/quality specialists, and more.
Speaker(s)
The Tapper Family, Sepsis Advocates
Wed, Sep 25 at 7:35 am PDT
Recognizing the Overlooked: Identifying Features of Delayed Sepsis Diagnoses (CE Session)
Overview
Description:
Date/Time: September 25, 2024 | 10:35 - 11:00 am ET
In this session, the presenters will explore the critical indicators of delayed or missed sepsis diagnoses using insights derived from a repository of Canadian medico-legal cases. Presented by Dr. Eileen Bridges, an emergency medicine specialist, and Dr. Gary Garber, an infectious disease specialist, attendees will identify features of delayed or missed diagnosis of sepsis and understand risks associated with undifferentiated patients. The session will also emphasize the importance of discharge instructions and communication with the patient and their family to improve patient safety.
Learning Objectives:
At the end of this session, the learner should be able to:
- Identify features of patients with delayed or missed diagnosis of infections;
- Summarize the importance of discharge instructions and communication with the patient to improve patient safety;
- Describe the risks associated with uncertainty in the undifferentiated patient.
Target Audience:
Nurses, advanced practice providers, physicians, emergency responders, pharmacists, medical technologists, respiratory therapists, physical/occupational therapists, infection prevention specialists, data/quality specialists, and more.
Speaker(s)
Gary Garber, MD, FRCPC, FACP, FIDSA, CCPE, Director, Safe Medical Care Research
Eileen Bridges, MD, CCFP, MSc, Dip Sport Med., Senior Physician Advisor, Safe Medical Care Learning
Wed, Sep 25 at 8:00 am PDT
A Sepsis Documentation Journey: Memorial Hospital of Union County (Ohio) (CE Session)
Overview
Description:
Date/Time: September 25, 2024 | 11:00 - 11:30 am ET
This presentation will give an overview of the Sepsis Core Measure compliance journey of a 99-bed independent hospital in Marysville, Ohio. Attendees will gain a clear understanding of the Sepsis Core Measure requirements, why they are crucial for patient outcomes, and how they impact hospital performance metrics. They will also learn about specific strategies and best practices implemented to enhance physician documentation related to sepsis. This session will include practical tips, tools used, and training methods that contributed to better compliance with the Sepsis Core Measure. Lastly, learners will also explore the lessons learned from the hospital’s journey, including challenges faced and how they were overcome. This will cover both successful tactics and areas for improvement, providing a comprehensive view of the impact on sepsis management and patient care quality.
Learning Objectives:
At the end of this session, the learner should be able to:
- Review the Sepsis Core Measure requirements and their importance;
- Identify key strategies for improving physician documentation;
- Analyze and compare the lessons learned and outcomes achieved to their own organizational sepsis protocols and documentation initiatives.
Target Audience:
Nurses, advanced practice providers, physicians, emergency responders, pharmacists, medical technologists, respiratory therapists, physical/occupational therapists, infection prevention specialists, data/quality specialists, and more.
Speaker(s)
Amy Stephens, MBA, RN, CPHQ, CHC, Assistant Vice President of Quality and Compliance
Robin Regula, RN, Clinical Quality Specialist
Wed, Sep 25 at 8:30 am PDT
Track 1: Recce Pharmaceuticals Sponsored Session: New Frontiers in Sepsis and Urosepsis Treatment: Synthetic Anti-Infectives to Combat Superbugs
Overview
Description:
Date/Time: September 25, 2024 | 11:30 am - 12:00 pm ET
Recce Pharmaceuticals Ltd (ASX: RCE, FSE: R9Q) is developing a New Class of Synthetic Anti-Infectives designed to address the urgent global health threat posed by antibiotic-resistant superbugs and emerging viral pathogens. With no new class of antibiotics in over 30 years, a novel class of medication that can tackle multidrug-resistant bacteria and does not increase antibiotic resistance is essential to tackle the constant infective threat. In this sponsored session, learn about Recce’s synthetic anti-infective compound, RECCE® 327 (R327), which has demonstrated bactericidal activity against all ESKAPEE pathogens (Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, Enterobacter spp., and Escherichia coli) without contributing to resistance. With a unique mechanism of action, the compound has the ability to continuously kill multidrug-resistant superbugs. Discover how Recce Pharmaceuticals Ltd is revolutionizing the fight against sepsis, urosepsis, and more with their innovative class of synthetic anti-infectives. With successful outcomes in Phase I/II trials and preparations for Phase III in Indonesia, Recce's RECCE® 327 shows significant promise against antibiotic-resistant superbugs.
Target Audience:
Nurses, advanced practice providers, physicians, emergency responders, pharmacists, medical technologists, respiratory therapists, physical/occupational therapists, infection prevention specialists, data/quality specialists, and more.
Speaker(s)
James Graham, Managing Director & Chief Executive Officer
Wed, Sep 25 at 8:30 am PDT
Track 2: Abionic Sponsored Session: Rapid Sepsis Screening - Can Pancreatic Stone Protein (PSP) Enhance ED Triage?
Overview
Description:
Date/Time: September 25, 2024 | 11:30 am - 12:00 pm ET
This sponsored session will cover existing sepsis assessment tools and their shortcomings and will introduce Pancreatic Stone Protein (PSP) as an emerging sepsis biomarker. The presenters will describe how PSP can be used as a complement to existing tools to enhance the ability of ED staff to screen incoming patients for Community Acquired Sepsis (CAS) and improve current "Rule-In" scores to ensure optimal patient outcome. Learners will also hear a real-world example of a use case for PSP which saved a young patient with sepsis in a Greek hospital.
Target Audience:
Nurses, advanced practice providers, physicians, emergency responders, pharmacists, medical technologists, respiratory therapists, physical/occupational therapists, infection prevention specialists, data/quality specialists, and more.
Speaker(s)
Andrew Shorr, MD, Section Director, Pulmonary and Critical Care Medicine
Evangelos J. Giamarellos-Bourboulis, MD, PhD, Professor of Internal Medicine and Infectious Diseases
Break: 12:00-12:15 ET / 9:00-9:15 PT
Please be sure to visit the exhibit booths and participate in the scavenger hunt during the break!
Wed, Sep 25 at 9:15 am PDT
Racial and Ethnic Disparities in Sepsis (CE Session)
Overview
Description:
Date/Time: September 25, 2024 | 12:15 - 12:45 pm ET
This session delves into the critical issue of racial and ethnic disparities in sepsis care and outcomes. Attendees will gain insights into sepsis-related definitions of equity and racism and examine the extent of these disparities within healthcare systems. The presentation will also explore various proposed mechanisms contributing to these disparities, assessing their validity and impact. How systemic factors influence sepsis outcomes among different racial and ethnic groups and the importance of addressing these inequities in clinical practice will also be highlighted.
Learning Objectives
At the end of this session, the learner should be able to:
- Restate sepsis-relevant definitions of equity and racism;
- Describe known racial and ethnic disparities relevant to sepsis care and outcomes;
- Evaluate the strength of proposed mechanisms for sepsis disparities.
Target Audience:
Nurses, advanced practice providers, physicians, emergency responders, pharmacists, medical technologists, respiratory therapists, physical/occupational therapists, infection prevention specialists, data/quality specialists, and more.
Speaker(s)
Christopher F. Chesley, MD, MSCE, Assistant Professor of Medicine
Wed, Sep 25 at 9:50 am PDT
Post-Intensive Care Syndrome in Survivors of Sepsis (CE Session)
Overview
Description:
Date/Time: September 25, 2024 | 12:50 - 1:20 pm ET
This presentation will explore the complex challenges faced by sepsis survivors who develop Post-Intensive Care Syndrome (PICS), delving into the intertwined physical, mental, and cognitive issues that arise. Attendees will gain insights into how PICS manifests in comparison to post-sepsis syndrome, highlighting both overlapping and distinct features. The session will also cover practical strategies to reduce the risk of PICS and promote early identification, empowering healthcare professionals to improve long-term outcomes for these vulnerable patients.
Learning Objectives:
At the end of this session, the learner should be able to:
- Describe the physical, mental health, and cognitive problems experienced by individuals with post-intensive care syndrome (PICS);
- Summarize the similarities and differences between post-sepsis syndrome and PICS;
- List strategies to decrease the risk of PICS and facilitate early detection.
Target Audience:
Nurses, advanced practice providers, physicians, emergency responders, pharmacists, medical technologists, respiratory therapists, physical/occupational therapists, infection prevention specialists, data/quality specialists, and more.
Speaker(s)
Tracye Proffitt, PhD, RN, CNE, Assistant Professor
Wed, Sep 25 at 10:25 am PDT
bioMérieux Sponsored Session: Comprehensive Clinical Solution Throughout the Acute Care Patient Journey
Overview
Description:
Date/Time: September 25, 2024 | 1:25 - 1:55 pm ET
In this sponsored session, attendees will learn how a comprehensive diagnostic portfolio including molecular, immunoassay, and microbiology solutions can support sepsis patient outcomes. The presenter will describe how laboratory diagnostics can lead to optimized therapy for patients suffering from sepsis. After the presentation, attendees will be able to design a strategy to optimize the use of rapid diagnostics upon implementation and will have a better understanding of the impact of sepsis.
Target Audience:
Nurses, advanced practice providers, physicians, emergency responders, pharmacists, medical technologists, respiratory therapists, physical/occupational therapists, infection prevention specialists, data/quality specialists, and more.
Speaker(s)
Daniel Feinstein, MD, MS, FACP, ACRP-PI, Director of Pulmonary Critical Care Medicine
Break: 1:55-2:10 ET / 10:55-11:10 PT
Please be sure to visit the exhibit booths and participate in the scavenger hunt during the break!
Wed, Sep 25 at 11:10 am PDT
Neonatal Sepsis: A Global Challenge (CE Session)
Overview
Description:
Date/Time: September 25, 2024 | 2:10 - 2:40 pm ET
Each year, nearly one million newborns die worldwide. Despite advances in global health, efforts to reduce deaths from neonatal sepsis have fallen behind. This is largely due to the challenges of delivering appropriate care for newborns, accurately identifying those who need treatment, and effectively managing sepsis in this vulnerable population. This presentation will focus on critical aspects of defining and enhancing the diagnosis of this life-threatening condition.
Target Audience:
Nurses, advanced practice providers, physicians, emergency responders, pharmacists, medical technologists, respiratory therapists, physical/occupational therapists, infection prevention specialists, data/quality specialists, and more.
Speaker(s)
Pascal Lavoie, MDCM, PhD, Professor of Pediatrics
Wed, Sep 25 at 11:45 am PDT
Sepsis: Threat to Cardiovascular Health (CE Session)
Overview
Description:
Date/Time: September 25, 2024 | 2:45 - 3:30 pm ET
Sepsis is associated with an increased risk of heart failure, atrial fibrillation, stroke, and other cardiovascular complications. This presentation will discuss the epidemiology of sepsis-associated cardiovascular disease, the concepts of cardiovascular risk factors and triggers, and the mechanisms by which sepsis may increase cardiovascular risk. In addition, the presenter will address the clinical implications of the association between sepsis and cardiovascular disease and outline areas for future research and clinical trials. Where appropriate, recommendations from clinical practice guidelines will be discussed.
Learning Objectives:
At the end of this session, the learner should be able to:
- Critically appraise the data on epidemiology of sepsis and cardiovascular disease;
- Describe the potential mechanisms by which sepsis may lead to cardiovascular risk;
- Review evidence-based recommendations to prevent and manage cardiovascular disease related to sepsis.
Target Audience:
Nurses, advanced practice providers, physicians, emergency responders, pharmacists, medical technologists, respiratory therapists, physical/occupational therapists, infection prevention specialists, data/quality specialists, and more.
Speaker(s)
Mitchell S. V. Elkind, MD, MS, FAHA, Chief Clinical Science Officer
Wed, Sep 25 at 12:35 pm PDT
Track 1: Roche Sponsored Session: Immunotherapy of Sepsis Guided by Biomarkers
Overview
Description:
Date/Time: September 25, 2024 | 3:35 - 3:50 pm ET
A major challenge in developing effective immune-modulatory therapies for sepsis is accurately assessing the functional state of a patient’s immune system at the time of treatment. Distinguishing between hyper-inflammatory and immunosuppressive phases is crucial for the success of these therapies. This sponsored session will explore innovative methods to classify (endotype) sepsis patients based on biomarkers, enabling more precise and effective treatment with immune-modulatory drugs. In this session, you will learn how these advancements can improve outcomes for sepsis patients by tailoring therapies to their biomarker-informed specific immune status.
Target Audience:
Nurses, advanced practice providers, physicians, emergency responders, pharmacists, medical technologists, respiratory therapists, physical/occupational therapists, infection prevention specialists, data/quality specialists, and more.
Speaker(s)
Richard Hotchkiss, MD, Professor of Anesthesiology, Medicine, and Surgery
Wed, Sep 25 at 12:35 pm PDT
Track 2: Flosonics Medical Sponsored Session: Cracking SEP-1: Your Guide to Acing Fluid Administration Requirements
Overview
Description:
Date/Time: September 25, 2024 | 3:35 - 3:50 pm ET
In this sponsored session, Director of Nursing Jaclyn Bond, MSN-LM, MBA-HM, RN will delve into the critical nuances of fluid administration in sepsis management, addressing the challenges and loopholes within the CMS SEP-1 guidelines. By reflecting on past practices and their impact on mortality rates, Jaclyn will highlight the advancements and current best practices in fluid responsiveness. The session will emphasize the role of FloPatch technology in making informed decisions about fluid administration, reducing the risk of secondary injury, and ensuring compliance. Attendees will gain practical knowledge on leveraging FloPatch assessments to optimize patient outcomes and navigate SEP-1 requirements effectively.
Target Audience:
Nurses, advanced practice providers, physicians, emergency responders, pharmacists, medical technologists, respiratory therapists, physical/occupational therapists, infection prevention specialists, data/quality specialists, and more.
Speaker(s)
Jaclyn Bond, MSN-LM, MBA-HM, RN, Director of Nursing
Wed, Sep 25 at 12:55 pm PDT
Track 1: InflaRx Sponsored Session: For Some Patients, COVID-19 Remains A Serious Threat
Overview
Description:
Date/Time: September 25, 2024 | 3:55 - 4:10 pm ET
This sponsored session will focus on the current demographics of patients who are at risk of developing pneumonia, sepsis, and acute respiratory distress syndrome (ARDS) in response to SARs-CoV-2 infection. The pathophysiology of COVID-19 will be described focusing on the involvement of the complement cascade responding to infection and how Gohibic® (vilobelimab) has an emergency use authorization for the treatment of COVID-19 in hospitalized adults when initiated within 48 hours of receiving invasive mechanical ventilation (IMV), or extracorporeal oxygenation (ECMO).
Target Audience:
Nurses, advanced practice providers, physicians, emergency responders, pharmacists, medical technologists, respiratory therapists, physical/occupational therapists, infection prevention specialists, data/quality specialists, and more.
Speaker(s)
Bruce P. Burnett, PhD, VP, Head of Medical Affairs
Wed, Sep 25 at 12:55 pm PDT
Track 2: SeaStar Medical Sponsored Session: Pediatric Sepsis, The Unique Fallout of a Global Killer
Overview
Description:
Date/Time: September 25, 2024 | 3:55 - 4:10 pm ET
In this sponsored session, learn about the global portfolio of sepsis as it relates to children. The presenter will identify the unique characteristics of pediatric sepsis and its short- and long-term consequences. Participants will also learn approaches to help improve sepsis-associated morbidity and mortality.
Target Audience:
Nurses, advanced practice providers, physicians, emergency responders, pharmacists, medical technologists, respiratory therapists, physical/occupational therapists, infection prevention specialists, data/quality specialists, and more.
Speaker(s)
Rajit K. Basu, MD, MS, FCCM, Division Chief of Critical Care Medicine
Wed, Sep 25 at 1:15 pm PDT
Advancing Health Equity for Sepsis Patients with Limited English Proficiency: Reducing Length of Stay and Readmissions (CE Session)
Overview
Description:
Date/Time: September 25, 2024 | 4:15 - 4:45 pm ET
This presentation explores the significance of culturally and linguistically appropriate services in enhancing outcomes for patients with sepsis and Limited English Proficiency (LEP). The design components of a Sepsis Nurse Navigation program tailored to address health inequities will be discussed, demonstrating how such initiatives can achieve positive patient outcomes. Incorporating iterative process improvement methodologies to address emerging gaps throughout project implementation will also be explored. Additionally, the session will evaluate demographic variables to identify potential health inequities and examine how the experiences of diverse populations can lead to opportunities for advancing health equity within organizations.
Learning Objectives
At the end of this session, the learner should be able to:
- Recognize how providing culturally and linguistically appropriate services meets the patients’ needs and improves outcomes for patients with Limited English Proficiency (LEP);
- Understand the design components of a Sepsis Nurse Navigation program that address specific health inequities to positively drive the intended and identified outcomes;
- Successfully design the inclusion of an iterative process improvement methodology throughout the duration of your project to address gaps identified after the onset of the project;
- Evaluate the demographic variables used to identify potential health inequities and explore how the unique experiences of these populations presently result in health equity opportunities within your organization.
Target Audience:
Nurses, advanced practice providers, physicians, emergency responders, pharmacists, medical technologists, respiratory therapists, physical/occupational therapists, infection prevention specialists, data/quality specialists, and more.
Speaker(s)
Moojan Rezvan, MBA, Supervisor, Interpreter Services & Diversity Services
Emily Cusick, BSN, RN, CCRN, Sepsis Clinical Coordinator
Wed, Sep 25 at 1:50 pm PDT
Day 1 Closing Remarks
Overview
Description:
Date/Time: September 25, 2024 | 4:50 - 5:00 pm ET
Target Audience:
Nurses, advanced practice providers, physicians, emergency responders, pharmacists, medical technologists, respiratory therapists, physical/occupational therapists, infection prevention specialists, data/quality specialists, and more.
Day 2: September 26, 2024
Expand each session and select "Watch Session" to access the individual session. Within the session, you can download the slides in the Handouts section, learn more about the speaker, description, and learning objectives, and access the video in the Course Contents section.
Thu, Sep 26 at 7:00 am PDT
Day 2 Opening Remarks: "By the Book": How a Journalist Survived Sepsis and Became an Advocate (CE Session)
Overview
Description:
Date/Time: September 26, 2024 | 10:00 - 10:15 am ET
Chronic illness consumed over half Jackie’s life and stumped even the most brilliant doctors from Baltimore to Washington, DC. It took nearly four decades to sort everything out. When it came to sepsis, she says she got lucky. She was a “textbook” case, which saved her life. During these opening remarks, Jackie will share how she survived, her lengthy recovery, and the advocacy work she is doing to ensure that those without a “textbook” case of sepsis will also be quickly diagnosed. World Sepsis Day is her birthday, and she’d like everyone affected by sepsis to be able to celebrate another trip around the sun.
Learning Objectives:
At the end of this session, the learner should be able to:
- Restate the importance of timely sepsis diagnosis;
- Discuss the lived experience and patient considerations related to “life after sepsis”.
Target Audience:
Nurses, advanced practice providers, physicians, emergency responders, pharmacists, medical technologists, respiratory therapists, physical/occupational therapists, infection prevention specialists, data/quality specialists, and more.
Speaker(s)
Jackie Duda, Health and Travel Journalist , Sepsis and Disability Advocate
Thu, Sep 26 at 7:20 am PDT
Day 2 Keynote: The Changing Climate of Infectious Diseases and Sepsis (CE Session)
Overview
Description:
Date/Time: September 26, 2024 | 10:20 - 10:50 am ET
Climate change is an all-encompassing crisis affecting all aspects of human health and disease. Local manifestations of the warming earth, such as shorter winters, changes in precipitation, and increased frequency of extreme weather events, will cause worldwide changes in the pathogens, and their vectors, responsible for severe infections including sepsis. These changes will alter infectious disease epidemiology in the US and internationally as traditionally accepted regions of disease acquisition lose relevance, seasonal associations change, and new pathogens emerge. This keynote talk will provide an overview of these changes, with an emphasis on pathogens that can cause sepsis.
Learning Objectives:
At the end of this session, the learner should be able to:
- Review the different ways that climate change affects vector-borne, zoonotic, and waterborne diseases;
- Describe how climate change can lead to the development and transmission of novel human pathogens;
- Explain the underlying factors associated with climate change that will alter the traditional epidemiology of infectious diseases.
Target Audience:
Nurses, advanced practice providers, physicians, emergency responders, pharmacists, medical technologists, respiratory therapists, physical/occupational therapists, infection prevention specialists, data/quality specialists, and more.
Speaker(s)
Matthew C. Phillips, MD, PhD, Clinical and Research Fellow
Thu, Sep 26 at 7:55 am PDT
Reducing Harm Related to Sepsis and Infections (CE Session)
Overview
Description:
Date/Time: September 26, 2024 | 10:55 - 11:25 am ET
During this session, the presenter will discuss key use cases for missed or delayed diagnoses and review improvement opportunities, particularly in the context of recognition of early decompensation. Learners will gain an understanding of the potential role, current barriers or shortcomings, and potential benefits of Artificial Intelligence (AI) in improving the detection and management of decompensation, as well as considerations around human factors and how those impact missed or delayed diagnosis of infection and sepsis.
Learning Objectives:
At the end of this session, the learner should be able to:
- Review harm related to missed or delayed diagnosis;
- Restate sepsis considerations both in and outside the ICU;
- Describe the role of Artificial Intelligence (AI) and human factors.
Target Audience:
Nurses, advanced practice providers, physicians, emergency responders, pharmacists, medical technologists, respiratory therapists, physical/occupational therapists, infection prevention specialists, data/quality specialists, and more.
Speaker(s)
David W. Bates, MD, MSc, Co-Director Artificial Intelligence and Bioinformatics in the Learning Healthcare System
Thu, Sep 26 at 8:30 am PDT
Track 1: Baxter Sponsored Session: Changing Landscape for Sepsis: Value-based Purchasing and The New CDC Hospital Sepsis Program Core Elements
Overview
Description:
Date/Time: September 26, 2024 | 11:30 am - 12:00 pm ET
Sepsis is a life-threatening syndrome of acute organ dysfunction secondary to infection, a common cause of hospitalization and death, and it contributes to new and worsening morbidity. Early sepsis recognition and appropriate management are key to positive outcomes. SEP-1 performance is now part of the CMS value-based purchasing (VBP) program. In August 2023, the CDC published the Hospital Sepsis Program Core Elements, which provides a ‘manager’s guide’ for developing a comprehensive program to monitor and improve outcomes from sepsis. This sponsored session will review SEP-1 as part of VBP and CDC’s 7 Core Elements for a Hospital Sepsis Program.
Target Audience:
Nurses, advanced practice providers, physicians, emergency responders, pharmacists, medical technologists, respiratory therapists, physical/occupational therapists, infection prevention specialists, data/quality specialists, and more.
Speaker(s)
Pat Posa RN, BSN, MSA, CCRN-K, FAAN, Quality and Patient Safety Program Manager
Thu, Sep 26 at 8:30 am PDT
Track 2: Wolters Kluwer Sponsored Session: The Human Impact of Sepsis Identification and Management
Overview
Description:
Date/Time: September 26, 2024 | 11:30 am - 12:00 pm ET
All members of the healthcare team have a role in the identification and treatment of sepsis and septic shock to reduce the negative impact of sepsis. Sepsis coordinators are at the heart of patient identification and navigating and interpreting sepsis alerting and data from the EHR. This session will discuss the instrumental role in identifying those meeting sepsis criteria, ensuring adherence to guidelines, and guiding documentation to ensure proper reimbursement for patients with sepsis.
Target Audience:
Nurses, advanced practice providers, physicians, emergency responders, pharmacists, medical technologists, respiratory therapists, physical/occupational therapists, infection prevention specialists, data/quality specialists, and more.
Speaker(s)
Elizabeth Tomaszewski, DNP, RN, CRNP, CNE, CCRN, ACNP-BC, ACNPC, Clinical Content Manager
Break: 12:00-12:15 ET / 9:00-9:15 PT
Be sure to visit the exhibit hall and participate in the scavenger hunt during the break!
Thu, Sep 26 at 9:15 am PDT
Hospital Care at Home in the Continuum of Care for Sepsis (CE Session)
Overview
Description:
Date/Time: September 26, 2024 | 12:15 - 12:45 am ET
Innovative hospital care at home programs can play a pivotal role in the continuum of care for sepsis patients. This session will illuminate how early discharge combined with hospital-level care at home can enhance patient experience and optimize bed capacity. Learn how to identify sepsis patients suitable for home care and discover the clinical advantages of this approach, including improved outcomes and patient satisfaction. The presenter will discuss the pathways and monitoring systems that ensure safe and effective care, demonstrating the transformative impact of this program on both patients and healthcare facilities and how home-based hospital care is reshaping sepsis management.
Learning Objectives:
At the end of this session, the learner should be able to:
- Identify patients who can be cared for in a Hospital Care at Home Program;
- Recognize the clinical benefits of enrolling in Hospital Care at Home.
Target Audience:
Nurses, advanced practice providers, physicians, emergency responders, pharmacists, medical technologists, respiratory therapists, physical/occupational therapists, infection prevention specialists, data/quality specialists, and more.
Speaker(s)
Grace Jenq, MD, Clinical Professor, Geriatric and Palliative Medicine; Associate Chief Clinical Officer, Post-Acute Care Services
Thu, Sep 26 at 9:50 am PDT
Sepsis Patient Education as Quality Improvement (CE Session)
Overview
Description:
Date/Time: September 26, 2024 | 12:50 - 1:20 pm ET
This session will focus on the critical role of patient education in improving sepsis outcomes. The presenter will discuss why educating patients about sepsis is vital for enhancing overall care quality and share a comprehensive pathway for standardizing sepsis education across a large healthcare system. Practical insights into the clinical nuances of implementing educational initiatives, including common pitfalls to avoid and effective strategies to adopt, will be explored. By integrating these educational efforts, healthcare providers can significantly boost patient understanding and engagement, ultimately driving better clinical outcomes and system-wide improvements.
Learning Objectives:
At the end of this session, the learner should be able to:
- Identify the importance and need for sepsis patient education;
- Present a pathway for standardizing sepsis education across a large healthcare system;
- List the clinical pearls and pitfalls of educational efforts in quality improvement work.
Target Audience:
Nurses, advanced practice providers, physicians, emergency responders, pharmacists, medical technologists, respiratory therapists, physical/occupational therapists, infection prevention specialists, data/quality specialists, and more.
Speaker(s)
Bethany Koschel, DO, Internal Medicine Physician
Thu, Sep 26 at 10:25 am PDT
T2 Biosystems Sponsored Session: Advancing Sepsis Detection in ICUs: Assessing the Benefits and Integration of T2Candida in Clinical Practice
Overview
Description:
Date/Time: September 26, 2024 | 1:25 - 1:40 pm ET
Candida infections in the ICU are particularly problematic due to their high mortality rates, the difficulty in rapid and accurate diagnosis, and the subsequent delays in initiating appropriate antifungal therapy. This session will discuss implementing the T2Candida Panel in ICU settings, where we will explore its impact on sepsis care. Topics include an introduction to the T2Candida diagnostic panel, identifying appropriate patient populations for testing, comparing T2Candida with Beta-D-Glucan, and best practices for integrating T2Candida into ICU workflows.
Target Audience:
Nurses, advanced practice providers, physicians, emergency responders, pharmacists, medical technologists, respiratory therapists, physical/occupational therapists, infection prevention specialists, data/quality specialists, and more.
Speaker(s)
Cristian Merchan, Pharm.D., BCCCP, Assistant Director of Clinical Pharmacy Services - Critical Care, Emergency and Perioperative Services
Thu, Sep 26 at 10:45 am PDT
Track 1: Cytovale Sponsored Session: IntelliSep Revolutionizes Early Sepsis Detection: Real Cases and a Patient Story
Overview
Description:
Date/Time: September 26, 2024 | 1:45 - 2:00 pm ET
Join Cytovale at the 2024 Sepsis Alliance Summit for a presentation about the IntelliSep sepsis test and its real-world impact on patients. Dive into patient cases from Our Lady of the Lake Regional Medical Center to discover how IntelliSep enables their providers to triage patients in the ED more quickly and confidently. You will also hear directly from a patient who was diagnosed with sepsis, and how she believes Our Lady of the Lake Regional Medical Center and IntelliSep saved her life.
Target Audience:
Nurses, advanced practice providers, physicians, emergency responders, pharmacists, medical technologists, respiratory therapists, physical/occupational therapists, infection prevention specialists, data/quality specialists, and more.
Speaker(s)
Hollis (Bud) O'Neal, MD, Associate Professor of Medicine
Mark Laperouse, MD, Medical Director, Emergency Services
Thu, Sep 26 at 10:45 am PDT
Track 2: Inflammatix Sponsored Session: Advances in Emergency Medicine Diagnostic Testing: Reducing Clinical Ambiguity with Patients Suspected of Acute Infections or Sepsis
Overview
Description:
Date/Time: September 26, 2024 | 1:45 - 2:00 pm ET
This sponsored session will present the unmet needs in assessing patients for acute infection and sepsis and the promise of host response as a better approach to address these needs. The presenter will discuss an FDA breakthrough designation and how the TriVerity™ Acute Infection and Sepsis test (Inflammatix, Inc.) may be used in routine care once cleared. The TriVerity Test is in development, is not for sale, and does not have marketing approval or clearance from regulatory authorities in any jurisdiction.
Target Audience:
Nurses, advanced practice providers, physicians, emergency responders, pharmacists, medical technologists, respiratory therapists, physical/occupational therapists, infection prevention specialists, data/quality specialists, and more.
Speaker(s)
Tim Sweeney, MD, PhD, Co-Founder and CEO
Break: 2:00-2:15 ET / 11:00-11:15 PT
Be sure to visit the exhibit hall and participate in the scavenger hunt during the break!
Thu, Sep 26 at 11:15 am PDT
Sepsis in the Cardiac Intensive Care Unit: Early Goal-Directed Mechanical Circulatory Support? (CE Session)
Overview
Description:
Date/Time: September 26, 2024 | 2:15 - 2:45 pm ET
During this session learners will assess sepsis diagnosis recognition and treatment recommendations in the Cardiac Intensive Care Unit. The presentation will explore myocardial dysfunction etiologies in sepsis, treatment approaches to cardiogenic shock alongside a sepsis diagnosis. Attendees will also explore mechanical circulatory support options with cardiogenic shock.
Learning Objectives:
At the end of this session, the learner should be able to:
- Review etiologies of myocardial dysfunction in the setting of sepsis;
- Discuss approach to cardiogenic shock in the setting of sepsis;
- Review mechanical circulatory support options in the setting of cardiogenic shock
Target Audience:
Nurses, advanced practice providers, physicians, emergency responders, pharmacists, medical technologists, respiratory therapists, physical/occupational therapists, infection prevention specialists, data/quality specialists, and more.
Speaker(s)
Jonathan Ludmir, MD, Assistant Professor of Medicine
Thu, Sep 26 at 11:50 am PDT
Earlier Recognition and Response to Critical Illness Outside the ICU (CE Session)
Overview
Description:
Date/Time: September 26, 2024 | 2:50 - 3:25 pm ET
This presentation will take attendees “back to the basics” by learning about the value of an Early Warning Assessment (EWA) and its components that complement Electronic Health Records early warning scores and algorithms. During the session, learners will explore current concerns related to ‘failure to rescue’ and review how an EWA can reduce missed early pathophysiology to facilitate prompt detection of sepsis and other critically ill patients. The pathophysiology identified by the EWA is linked to Rapid Response Team protocolized interventions so that treatments are delivered early during clinical decline, a time in which they have the most benefit; thus, reducing hospital morbidity, mortality, and cost.
Learning Objectives:
At the end of this session, the learner should be able to:
- Review current data about bedside exam techniques used for early recognition of sepsis and other critical illness;
- Identify key components of a focused bedside head-to-toe assessment;
- List benefits of utilizing EWA to develop protocolized interventions.
Target Audience:
Nurses, advanced practice providers, physicians, emergency responders, pharmacists, medical technologists, respiratory therapists, physical/occupational therapists, infection prevention specialists, data/quality specialists, and more.
Speaker(s)
Frank Sebat, MS, MS, FCCM, Co-Chair, "Recognizing and Responding to Critical Illness Outside ICU"
Thu, Sep 26 at 12:30 pm PDT
Boston Scientific Sponsored Session: Intrarenal Pressure During Flexible Ureteroscopy
Overview
Description:
Date/Time: September 26, 2024 | 3:30 - 3:55 pm ET
In this sponsored session, Dr. Manoj Monga will share why endourologists should care about intrarenal pressure during flexible ureteroscopy and percutaneous nephrolithotomy (PCNL.) He will discuss the consequences of high intrarenal pressure and how to decrease intrarenal pressure during endoscopic procedures. Then, Dr. Ben H. Chew and Dr. Naeem Bhojani will discuss risk factors for urosepsis after ureteroscopy, the importance of intrarenal pressure (IRP) monitoring, and their clinical experiences using the next-gen LithoVue™ Elite Single-Use Digital Flexible Ureteroscope System with IRP monitoring.
Target Audience:
Nurses, advanced practice providers, physicians, emergency responders, pharmacists, medical technologists, respiratory therapists, physical/occupational therapists, infection prevention specialists, data/quality specialists, and more.
Speaker(s)
Manoj Monga, MD, FACS, FRCS, Professor and Chair of Department of Urology
Naeem Bhojani, MD, Professor of Surgery
Ben H. Chew, MD, MSc, FRCSC, Associate Professor of Urology
Thu, Sep 26 at 1:00 pm PDT
Use of Virtual Reality for Sepsis Recognition and Management Training (CE Session)
Overview
Description:
Date/Time: September 26, 2024 | 4:00 - 4:15 pm ET
In this session, attendees will discover the transformative potential of virtual reality (VR) in enhancing medical training for sepsis recognition and management . The presenter will discuss the limitations of current training methods and demonstrate how VR can bridge these gaps, offering immersive, hands-on experiences that traditional approaches lack. Attendees will gain insights into the application of VR technology, including detailed examples of its successful use in training scenarios. Understanding how VR not only improves competency in sepsis recognition but also provides a robust platform for assessment and continuous learning - crucial in how cutting-edge technology is revolutionizing medical education and patient care.
Learning Objectives:
At the end of this session, the learner should be able to:
- Identify the gaps in standard modalities for training on the recognition of sepsis;
- Restate how virtual reality can fill gaps in the training of sepsis recognition;
- Describe how virtual reality has been used for training and assessment on sepsis recognition and management.
Target Audience:
Nurses, advanced practice providers, physicians, emergency responders, pharmacists, medical technologists, respiratory therapists, physical/occupational therapists, infection prevention specialists, data/quality specialists, and more.
Speaker(s)
Matthew Zackoff, MD, MEd, Assistant Professor, Division of Critical Care Medicine
Thu, Sep 26 at 1:20 pm PDT
Day 2 Closing Remarks
Overview
Description:
Date/Time: September 26, 2024 | 4:20 - 4:30 pm ET
Target Audience:
Nurses, advanced practice providers, physicians, emergency responders, pharmacists, medical technologists, respiratory therapists, physical/occupational therapists, infection prevention specialists, data/quality specialists, and more.
Instructions to Access Sessions and earn CE Credits
- Today's sessions will run on one continuous Zoom. You must attend the full day to be eligible for CE credits for Day 3.
Day 3, September 27, 2024
Opening Remarks and Land Acknowledgement
Agenda:
Time (ET) | Session Title | Presenter |
---|---|---|
10:00-10:10 | Opening Remarks and Land Acknowledgment | David Carlbom, MD Associate Professor of Medicine, Pulmonary Critical Care and Sleep Medicine University of Washington School of Medicine Medical Director, Respiratory Care Department Attending Physician, Medical and Trauma-Surgical Intensive Care Units Harborview Medical Center Katy Grainger Sepsis Survivor and Advocate |
Speaker Biographies:
David Carlbom, MD
David Carlbom, MD, is the Medical Director, Respiratory Care Department and Attending Physician in the Medical and Trauma-Surgical Intensive Care Units at Harborview Medical Center. He is also an Associate Professor of Medicine, Pulmonary Critical Care & Sleep Medicine, Department of Medicine, at the University of Washington School of Medicine.
His passion is in early recognition and early resuscitation of critically ill patients. He is actively involved in leadership and teaching activities at the local, regional, and international level. He is a major resource for sepsis resuscitation and pre-ICU critical care expertise at UW Medicine. He lectures extensively to multiple different professionals and works systematically to identify and initiate rapid treatment of critically ill sepsis patients. In 2020, he was awarded the individual Global Sepsis Award in recognition for his commitment to educate others about sepsis. His bias is “good people trying hard, of any educational level, can take great care of critically ill patients if they work as a team, communicate, and have compassion for humans.”
Katy Grainger
In September 2018, Katy’s life was turned upside down when she nearly died from septic shock because of a small, infected cut on her thumb. Because of complications from sepsis, she now lives as a bilateral below-knee amputee who also lost seven partial fingers. One in five deaths worldwide are caused by sepsis, yet few people have heard of it and even fewer can identify the signs and symptoms. Katy has made it her mission to do everything she can to prevent others from experiencing what she went through.
Katy serves on the Board of Directors of Sepsis Alliance and shares her story to highlight this important public health crisis. She has reached millions of people with information about sepsis and disability through social media channels, articles, podcasts and speaking engagements. She has impacted medical policy in the United States by speaking to policy makers in Washington DC, Hawaii and Washington State. Katy has become a body inclusive model and actor. She is currently writing a book about her journey with sepsis and amputations, highlighting the patient experience, lessons learned and the strength she had gained.
Session 1: Implementation of Pediatric Sepsis Phoenix Criteria Across the Globe: Building Equity?
Description:
The new Pediatric Sepsis Phoenix Criteria released in 2024 by the Society of Critical Care Medicine (SCCM) Pediatric Sepsis Definition Task Force sought to develop and validate new clinical criteria for pediatric sepsis and septic shock using measures of organ dysfunction through a data-driven approach. SCCM used a retrospective cohort of patients in ten health systems in the US, Colombia, Bangladesh, China, and Kenya, three of which were used as external validation sites. The Phoenix Sepsis Score was developed and validated using markers of organ dysfunction with a higher positive predictive value and higher or similar sensitivity compared with the 2005 International Pediatric Sepsis Consensus Conference (IPSCC) criteria. How will this be implemented across the globe? Can it work in Low- & Middle-Income locations?
Learning Objectives:
At the end of this session, the learner will be able to:
- Describe how Pediatric Sepsis Phoenix Criteria was developed.
- Design methods to best implement across the globe.
- Ideate and develop next steps to best apply in all clinical settings.
Agenda:
Time (ET) | Session Title | Presenter |
---|---|---|
10:10-10:15 | Introductions | Moderator: Scott P. Sherry, MS, PA-C, FCCM Sepsis Program Manager Oregon Health and Science University Doernbecher Children’s Hospital |
10:15-10:30 | Development of the Phoenix Criteria for Sepsis and Septic Shock in Children | L. Nelson Sanchez-Pinto, MD, MBI, FAMIA Northwestern University - Feinberg School of Medicine |
10:30-10:45 | The Phoenix Pediatric Sepsis Definitions - Applying Them in South Africa | Andrew Argent, MBBCh, MMed, MD, FRCPCH (UK) Professor Emeritus University of Cape Town |
10:45-10:55 | Panel Discussion | David Carlbom, MD Nelson Sanchez-Pinto, MD, MBI, FAMIA Andrew Argent, MBBCh, MMed, MD, FRCPCH(UK) |
Sessions and Speakers:
Moderator: Scott P. Sherry, MS, PA-C, FCCM
Development of the Phoenix Criteria for Sepsis and Septic Shock in Children
Learning Objectives:
1. Describe the development of the Phoenix Sepsis Score and the new criteria for sepsis;
2. Identify the key differences between the previous pediatric sepsis criteria and the updated Phoenix criteria;
3. Restate the implications of implementing the Phoenix sepsis criteria in clinical practice, including its potential impact on timely diagnosis and clinical management, research, and improving patient outcomes.
L. Nelson Sanchez-Pinto, MD, MBI, FAMIA
L. Nelson Sanchez-Pinto, MD, MBI, FAMIA, is a pediatric critical care physician, biomedical informatics specialist, and data science researcher at Northwestern University Feinberg School of Medicine and Ann & Robert H. Lurie Children's Hospital of Chicago. His research focuses on applying data science and artificial intelligence approaches to improve the care provided to acutely ill patients, with a particular focus on pediatric sepsis.
The Phoenix pediatric sepsis definitions – applying them in South Africa
Learning Objectives:
1. Describe the contextual information of health services and their interactions with children suffering from sepsis in South Africa (and in sub-Saharan Africa)
2. Restate the challenges and objectives of applying the pediatric sepsis definitions to the care of critically ill children in South Africa, addressing the question of how to “think globally and act locally”
3. Describe processes currently in place (and are being considered) to translate the definitions into clinical practice and collect data on patients identified as having sepsis.
Andrew Argent, MBBCh, MMed, MD (Paediatrics), FRCPCH (UK)
Andrew Argent, MBBCh, MMed, MD, FRCPCH(UK) has worked in critical care in Cape Town for more than 30 years and directed the largest pediatric intensive care unit in Africa until 2019. He is a past President of the World Federation of Pediatric Intensive and Critical Care societies. Although retired, he remains involved in the development of clinical approaches to the recognition and management of sepsis in children. He has a particular interest in the provision of care to critically ill children in countries across the world and has been involved in the development and implementation of training programs for healthcare workers in pediatric critical care. Dr. Argent continues to be involved in consultations regarding multiple aspects of the care of critically ill children.
Session 2: Challenges & Opportunities for Improving Maternal Sepsis Care
Description:
Maternal sepsis is the third most common cause of maternal mortality during pregnancy, childbirth, post-abortion, or the postpartum period. Despite this sobering fact, it is often under-recognized and treated differently across the globe. Come learn about the impact of maternal sepsis, updates in systems approach to improving care, and utilizing new maternal sepsis guidelines in your own practice to improve patient outcomes.
Learning Objectives:
At the end of this session, the learner will be able to:
- Compare & contrast maternal sepsis care in different resource settings;
- Describe new maternal sepsis guidelines.
Agenda:
Time (ET) | Session Title | Presenter |
---|---|---|
11:00-11:05 | Introductions | Moderator: Scott P. Sherry, MS, PA-C, FCCM Sepsis Program Manager Oregon Health and Science University Doernbecher Children’s Hospital |
11:05-11:18 | Midwives’ role in preventing maternal and neonatal sepsis in Low- and Middle-Income Countries | Cathryn Ellis. BFA, MSc. PhD, RM (non-practicing)
Associate Professor Emeritus University of British Columbia |
11:18-11:31 | Addressing Maternal Sepsis: A Large-Scale Quality Improvement Approach | Elliott K. Main, MD Professor of Obstetrics and Gynecology Stanford University School of Medicine |
11:31-11:44 | Practical approaches to addressing maternal sepsis in Low-to-Middle Income Countries | María Fernanda Escobar Vidarte, MD Chief of the Global Health Equity Unit Fundacion Valle del Lili |
11:44-11:55 | Panel Discussion |
Sessions and Speakers:
Moderator: Scott P. Sherry, MS, PA-C, FCCM
Midwives’ role in preventing maternal and neonatal sepsis in Low- and Middle-Income Countries
Learning Objectives:
1. Recognize ways that midwives in LMIC’s prepare the environment to prevent infections;
2. Discuss how working with communities can increase access to timely care and prevent maternal infection;
3. Describe ways that midwifery education reduces pathways to infection at birth in Nepal, Somalia and Somaliland;
4. Discuss barriers to reducing maternal and neonatal infection in LMICs.
Cathryn Ellis. BFA, MSc. PhD, RM (non-practicing)
Dr. Cathryn Ellis is an Associate Professor Emeritus at the University of British Columbia, where she taught in the UBC Midwifery Program from 2004 to 2022. She was lead for UBC’s Midwifery Global Placement from 2004 to 2024 and developed a global maternal-infant health theory and practice course for UBC health science students. Her special interest in global midwifery and maternal-infant care has led her to teach community-level and university-trained midwives in Mexico, Nicaragua, Kosovo, Zambia, Uganda, Bangladesh, Nepal, South Sudan, Somalia, and Somaliland. With a PhD in Global Health from Simon Fraser University, Cathy's research and practice focus on improving maternal health outcomes in remote and underserved communities. She is currently the UBC lead for CAM’s Strengthening Midwifery Education and Practice in Somalia project.
Addressing Maternal Sepsis: A Large-Scale Quality Improvement Approach
Learning Objectives:
1. Identify the reasons that obstetric sepsis is different that sepsis in other populations;
2. Describe the rationale for a two-step approach to screening and diagnosis of obstetric sepsis;
3. Describe how improving care for sepsis can be a model for addressing multiple causes of Severe Maternal Morbidity.
Elliott K. Main, MD
Elliott Main, MD founded and directed the California Maternal Quality Care Collaborative (CMQCC) for 16 years until 2023 and served as the Chair of the California Maternal Mortality Review Committee during those years. Nationally, Dr. Main is the co-founder and currently the lead for QI Implementation for Alliance for Innovation on Maternal Health ( AIM), the national project, funded thru the Health Resources and Services Administration ( HRSA) and based at American College of Obstetricians and Gynecologists (ACOG), for supporting state Perinatal Quality Collaboratives in their efforts to reduce maternal mortality and severe morbidity. He has coauthored multiple California Maternal Quality of Care Collaborative (CMQCC) Toolkits and AIM National Safety Bundles including recent one on obstetric sepsis. Currently Dr Main is co-principal investigator with Dr. Melissa Bauer of an NIH sponsored two-state quality improvement collaborative to reduce maternal sepsis. Dr. Main is Professor of Obstetrics and Gynecology at Stanford University in the Dunlevie Division of Maternal Fetal Medicine.
Practical approaches to addressing maternal sepsis in Low-to-Middle Income Countries
Learning Objectives:
1. Determine the impact of maternal sepsis in LMIC;
2. Formulate a simple and applicable diagnostic proposal for maternal sepsis, from low to high complexity;
3. Establish a management protocol for maternal sepsis by the intervention packages (bundles).
María Fernanda Escobar Vidarte, MD
María Fernanda Escobar Vidarte, MD is a Gynecologist and Obstetrician from the Universidad del Valle, Cali- Colombia; specialist in Critical Medicine and Intensive Care from the Universidad del Valle and the University of Pittsburgh, USA. Dr. Escobar-Vidarte holds a master’s degree in Clinical Epidemiology from the Universidad de la Frontera, Temuco- Chile and a master’s degree in Management for Social Innovation from the ICESI University, Cali. Currently, Dr. Escobar-Vidarte is Chief of the Global Health Equity Unit and leader of the Hospital Padrino strategy of the Fundacion Valle del Lili and Colombia in alliance with the Ministry of Health of Colombia. She is a professor at the Faculty of Medicine of the Icesi University, Cali – Colombia, and a mentor of the same university's Obstetrics and Gynecology research group. She has represented Latin America in the Safe Motherhood and Childbirth Health Committee of the International Federation of Gynecology and Obstetrics (FIGO). Dr. Escobar-Vidarte is also a consultant to the Pan American Health Organization (PAHO) and the World Health Organization (WHO).
Session 3: Bedside Education - Teaching Providers How to Apply Best Practices
Description:
Guidelines for best practice are often created to provide the safest recommendations for the widest possible population of patients. When applied to syndromes such as sepsis this may cause a lack of precision care for individual patients. During this session attendees will learn how to apply guidelines to specific patients and maintain optimism for guideline use by providers in various care settings, using examples of the growing crisis around Antimicrobial Resistance in African nations.
Learning Objectives:
At the end of this session, the learner will be able to:
- List one example of how to identify champions from interdisciplinary teams to effect durable knowledge translation that one can try in practice;
- Review how resource-constrained settings change techniques of engagement or pedagogical strategies;
- Apply specific patient and context considerations to implementing clinical practice guidelines;
- Reflect on major challenges related to resistance in clinical practice, innovation, financial models and equal distribution of medicines.
Agenda:
Time (ET) | Session Title | Presenter |
---|---|---|
12:30-12:35 | Introductions | Moderator: Rick Janik, BSN, RN, CEN, CFRN Flight Nurse Airlift Northwest |
12:35-12:53 | The Hard Part - Turning Guidelines Into Practice | Laura Evans, MD, MSc Professor and Medical Director, Critical Care University of Washington |
12:53-1:11 | Transformational Leadership: People-Centered Framework to Address Antimicrobial Resistance, the Silent Tsunami! | Halima Salisu-Kabara, FWACN, MPA, RN-RM, CCRN Vice-Executive Director African Sepsis Alliance (ASA) |
1:11-1:25 | Panel Discussion |
Sessions and Speakers:
Moderator: Rick Janik, BSN, RN, CEN, CFRN
The Hard Part - Turning Guidelines Into Practice
Learning Objectives:
1. Describe the strengths and the limitations of clinical practice guidelines for sepsis;
2. Apply specific patient and context considerations to implementing clinical practice guidelines.
Laura Evans, MD, MSc
Laura Evans, MD, MSc is a professor of medicine at the University of Washington and the Medical Director of Critical Care at the University of Washington Medical Center. Her interests focus on sepsis and preparedness for high-consequence infectious diseases, particularly on guideline development and implementation, and patient safety/quality improvement.
Dr. Evans earned her medical degree at the University of Michigan and did her residency in internal medicine at Columbia University. She completed pulmonary and critical care medicine fellowship training and earned a Master of Science in epidemiology at the University of Washington. She then joined the New York University and Bellevue Hospital faculty in 2006. In her role there, she led the evacuation of the Bellevue Hospital intensive care units in the aftermath of Hurricane Sandy. She was the clinical lead for New York City’s only patient with Ebola. She was associate program director for the pulmonary and critical care fellowship program at NYU for more than 10 years. After 14 years in NYC, she returned to Seattle in 2019.
She joined the steering committee of the Surviving Sepsis Campaign (SSC) in 2012 and was the co-chair of the past 2 revisions of the Surviving Sepsis Campaign adult sepsis guidelines, and SSC COVID management guidelines co-chair. She also served as the critical care team lead for the National Institutes of Health COVID Management Guidelines. She is the current chair of the American Board of Internal Medicine’s Critical Care Medicine specialty board.
Transformational Leadership: People-Centered Framework to Address Antimicrobial Resistance, the Silent Tsunami!
Learning Objectives:
1. Recognize antimicrobial resistance and identify the actions needed to address this increasingly serious global health threat;
2. Reflect on major challenges related to resistance in clinical practice, innovation, financial models and equal distribution of medicines;
3. Describe the extent of the Antimicrobial Resistance crisis, and accept transformational leadership as a model for policy change.
Halima Salisu-Kabara, FWACN, MPA, RN-RM, CCRN
Halima Salisu Kabara, FWACN, MPA, RN-RM, CCRN is a Practice Development Consultant, and the Sepsis Coordinator for SIDOK Sepsis Research Group, a multidisciplinary team in Nigeria. Her vision is to reduce preventable deaths due to sepsis in Nigeria and Africa and provide patient-centered equitable care in low-resource countries.
She is proudly an EECC Champion and a Sepsis Ambassador. She is the Vice-Executive Director of the African Sepsis Alliance (ASA), and a Board member of the Global Sepsis Alliance (GSA).
Session 4: Bench to Bedside: Updates in Sepsis Science
Description:
The scientific basis of sepsis care is constantly changing, as thousands of researchers produce literature on how to improve sepsis diagnosis and treatment. This enormous body of work is impossible for busy clinicians to sort through. Come listen to an expert in evaluation of literature quality identify and discuss the most impactful new evidence around sepsis.
Learning Objectives:
At the end of this session, the learner will be able to:
- Demonstrate efficient bedside diagnostic clues and strategies to identifying sepsis;
- Contrast “low-resource” and “high-resource” sepsis interventions, discussing which are of greatest impact to patients.
Agenda:
Time (ET) | Session Title | Presenter |
---|---|---|
1:30-1:35 | Introductions | Moderator: Mary Jo Kelly DNP, ARNP-CNS, CCNS, CCRN System Level Clinical Nurse Specialist Providence Swedish Health System |
1:35-2:20 | Sepsis Research Update: Considerations for All Care Settings | Elizabeth Bridges PhD, RN, CCNS, FCCM, FAAN Professor Emeritus, Biobehavioral Nursing and Health Informatics University of Washington Medical Center |
2:20-2:25 | Q&A |
Sessions and Speakers:
Moderator: Mary Jo Kelly DNP, ARNP-CNS, CCNS, CCRN
Sepsis Research Update: Considerations for All Care Settings
This presentation addresses three issues related to sepsis resuscitation: current research related to the selection of resuscitation fluids (saline vs balanced solutions), noninvasive assessment strategies, including considerations for individuals with darker skin tone, and the integration of macro- and microhemodynamic assessments to guide sepsis resuscitation.
Learning Objectives:
1. Summarize current research related to saline versus balanced solutions for sepsis resuscitation;
2. Identify options/limitations of noninvasive hemodynamic assessments;
3. Outline personalized management resuscitation/management strategies.
Elizabeth Bridges PhD, RN, CCNS, FCCM, FAAN
Elizabeth Bridges, PhD, RN, CCNS, FCCM, FAAN has over 40 years of experience in critical care. She retired as a professor from the University of Washington School of Nursing/University of Washington Medical Center and is a retired colonel of the United States Air Force Nurse Corps. Her research focuses on the care of patients during long-distance military aeromedical evacuation and austere operational settings and the integration of hemodynamics into the care of critically ill patients. She is the editor of the TriService Nursing Research Program Battlefield and Disaster Nursing Pocket Guide, which is currently being translated into Ukrainian. She served as the President of the American Association of Critical Care Nurses in 2020-2021. Dr. Bridges is well known for her presentations on the integration of evidence into practice that includes multiple topics related to sepsis, hemodynamics, and operational care.
Session 5: Sepsis Survivorship
Agenda:
Time (ET) | Session Title | Presenter |
---|---|---|
2:30-2:35 | Introductions | Moderator: Sybil Hoiss, RN, MN Lead, Clinical Initiatives & Innovation Critical Care BC, Provincial Health Services Authority |
2:35-2:43 | Journey to Sepsis Survivorship: Patient Perspective | Hailey Bain
Sepsis Survivor and Patient Partner Sepsis Canada |
2:43-2:56 | Sepsis Aftercare: Improving the Lives of Sepsis Survivors | Mark E. Mikkelsen, MD, MSCE, FCCM Associate Chief Medical Officer, Critical Care University of Colorado Hospital |
2:56-3:09 | Sepsis Transition and Recover (STAR), Nurse Navigators Delivering Best Practice Post-Discharge Care | Stephanie Taylor, MD, MS Division Chief of Hospital Medicine University of Michigan |
3:09-3:25 | Panel Discussion |
Sessions and Speakers:
Moderator: Sybil Hoiss, RN, MN
Journey to Sepsis Survivorship: Patient Perspective
Hailey Bain
Hailey Bain is a 27-year-old sepsis survivor from Toronto, Canada. She experienced a ruptured appendix and was misdiagnosed, causing septic shock at the age of 23. Currently, she is a Patient Partner at Sepsis Canada and an active member of their Patient Advisory Council. She hopes by sharing her experience of surviving sepsis, patients can learn to advocate for their health and healthcare professionals can better understand the implications of sepsis.
Sepsis Aftercare: Improving the Lives of Sepsis Survivors
Learning Objectives:
1. Identify the long-term health consequences experienced by adult sepsis survivors;
2. Describe how to educate patients more effectively about the timing and causes of hospital readmission after sepsis;
3. Develop partnerships with post-acute care to implement strategies to enhance recovery after sepsis.
Mark E. Mikkelsen, MD, MSCE, FCCM
Mark E. Mikkelsen, MD, MSCE, FCCM is the Associate Chief Medical Officer for Critical Care at the University of Colorado Hospital. Dr. Mikkelsen served as the Co-Chair of the Society of Critical Care Medicine's Thrive: Supporting Survivors of Critical Illness Initiative for 6 years. He has partnered with CMS and state hospital and healthcare associations to improve care coordination and reduce hospital readmissions for sepsis survivors.
Sepsis Transition and Recover (STAR), Nurse Navigators Delivering Best Practice Post-Discharge Care
Learning Objectives:
1. List common complications experienced by sepsis survivors after hospital discharge;
2. Identify best practices for caring for patients after a sepsis hospitalization;
3. Describe health system strategies for providing best-practice transition and recovery care for sepsis survivors.
Stephanie Taylor, MD, MS
Stephanie Taylor, MD, MS focuses her research on improving patient outcomes and developing innovative practices to promote optimal care for sepsis in both early antibiotic management and post-discharge transition and recovery. She employs her expertise in health services research, pragmatic trials, large datasets, and implementation science to identify and address essential healthcare questions related to quality, value, and equity of care. Dr. Taylor is also the Division Chief of Hospital Medicine.
Closing Remarks: Pulling It All Together
Agenda:
Time (ET) | Session Title | Presenter |
---|---|---|
03:30-04:00 | Closing Remarks: Pulling It All Together | Fatima Sheikh, MSc PhD Candidate, Department of Health Research Methods, Evidence, and Impact Communications Assistant, Sepsis Canada Katy Grainger Sepsis Survivor and Advocate |
Speaker Biographies:
Fatima Sheikh, MSc
Fatima Sheikh is a PhD student in the Health Research Methodology program at McMaster University. Her research aims to investigate the effects of social determinants of health on the incidence and outcomes of sepsis; and develop knowledge of the effects of social determinants of health on healthcare to inform health policy, responsible use of evidence, and equitable healthcare practices. She hopes that training in both research and teaching will allow her to develop the skills and aptitudes to establish a program of research focused on equitable healthcare practices, specifically within critical care.
Katy Grainger
In September 2018, Katy’s life was turned upside down when she nearly died from septic shock because of a small, infected cut on her thumb. Because of complications from sepsis, she now lives as a bilateral below-knee amputee who also lost seven partial fingers. One in five deaths worldwide are caused by sepsis, yet few people have heard of it and even fewer can identify the signs and symptoms. Katy has made it her mission to do everything she can to prevent others from experiencing what she went through.
Katy serves on the Board of Directors of Sepsis Alliance and shares her story to highlight this important public health crisis. She has reached millions of people with information about sepsis and disability through social media channels, articles, podcasts and speaking engagements. She has impacted medical policy in the United States by speaking to policy makers in Washington DC, Hawaii and Washington State. Katy has become a body inclusive model and actor. She is currently writing a book about her journey with sepsis and amputations, highlighting the patient experience, lessons learned and the strength she had gained.
CE Evaluation
Access Date | Quiz Result | Score | Actions |
---|